Found: 21
Select item for more details and to access through your institution.
Detection of Novel Influenza Viruses Through Community and Healthcare Testing: Implications for Surveillance Efforts in the United States.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13315
- By:
- Publication type:
- Article
Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13309
- By:
- Publication type:
- Article
Avian Influenza Virus (H5N1) Was Not Detected Among Dairy Cattle and Farm Workers in Pakistan.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13317
- By:
- Publication type:
- Article
The Detection of Influenza Virus Before and During the COVID‐19 Pandemic in Cameroon.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13313
- By:
- Publication type:
- Article
Prevalence of Respiratory Viruses in Children With Acute Respiratory Infections in Shanghai, China, From 2013 to 2022.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13310
- By:
- Publication type:
- Article
Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross‐Sectional Study From 2014 to 2019.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13307
- By:
- Publication type:
- Article
Descriptive Epidemiology of Travel and Non‐Travel Related SARS‐CoV‐2 Gamma (P.1/501Y.V3) Variant Cases in England, 2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13308
- By:
- Publication type:
- Article
SARS‐CoV‐2 Reverse Zoonosis Among Cats in China: A One Health Investigation.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13306
- By:
- Publication type:
- Article
Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID‐19: Results From Four Health Systems, 2015–2023.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13298
- By:
- Publication type:
- Article
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13302
- By:
- Publication type:
- Article
Risk Factors for Severe COVID‐19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020–2022.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13300
- By:
- Publication type:
- Article
Evaluating Seasonal Variations in Human Contact Patterns and Their Impact on the Transmission of Respiratory Infectious Diseases.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13301
- By:
- Publication type:
- Article
Respiratory Syncytial Virus and Influenza Infections in Children in Ulaanbaatar, Mongolia, 2015–2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13303
- By:
- Publication type:
- Article
Estimating the Undetected Burden of Respiratory Syncytial Virus Hospitalizations in Adults Through Capture–Recapture Methods.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13299
- By:
- Publication type:
- Article
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13284
- By:
- Publication type:
- Article
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13294
- By:
- Publication type:
- Article
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13295
- By:
- Publication type:
- Article
Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13290
- By:
- Publication type:
- Article
Impact of the COVID‐19 Pandemic on Influenza Circulation During the 2020/21 and 2021/22 Seasons, in Europe.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13297
- By:
- Publication type:
- Article
Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13275
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Influenza & Other Respiratory Viruses, 2024, v. 18, n. 5, p. 1, doi. 10.1111/irv.13157
- Publication type:
- Article